| Literature DB >> 30747421 |
Madia Lozupone1, Maddalena La Montagna2, Francesca D'Urso2, Antonio Daniele3,4, Antonio Greco5, Davide Seripa5, Giancarlo Logroscino1,6, Antonello Bellomo2, Francesco Panza7,8,9.
Abstract
Psychiatric illnesses are cognitive and behavioral disorders of the brain. At present, psychiatric diagnosis is based on DSM-5 criteria. Even if endophenotype specificity for psychiatric disorders is discussed, it is difficult to study and identify psychiatric biomarkers to support diagnosis, prognosis, or clinical response to treatment. This chapter investigates the innovative biomarkers of psychiatric diseases for diagnosis and personalized treatment, in particular post-genomic data and proteomic analyses.Entities:
Keywords: Biomarker; Bipolar disorder; Depressive disorder; Epigenetics; Lifestyle; Microbiota; Post-genomic diagnostics; Proteomics; Psychiatric disease; Schizophrenia
Mesh:
Substances:
Year: 2019 PMID: 30747421 DOI: 10.1007/978-3-030-05542-4_7
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622